Skip to main content
SpringerLink
Log in
Book cover

Biological Response Modifiers in Human Oncology and Immunology pp 241–259Cite as

Isoprinosine and NPT 15392: Immunomodulation and Cancer

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 166))

Abstract

In cancer, there appears to be a direct relationship between immunosuppression and the ability of neoplastic cells to flourish. Because the immune system is compromised, tumor growth is unchecked by the normal immune regulatory mechanisms. For this reason it has been suggested that immunomodulators, agents that directly affect immune function, might be used therapeutically in the treatment of cancer. Such compounds could restore the body’s capacity to mount an immunologic response leading to the eventual destruction of the neoplasm. Perhaps better supported by clinical evidence, is the possible use of immunomodulators as adjuvants to standard cancer therapies, such as chemotherapy or radiotherapy. The generalized immunosuppression resulting from these procedures often leads to severe problems with opportunistic infections. Used in combination with standard chemotherapy or radiotherapy, immunomodulators might speed the recovery of normal immune function thereby not only reducing the incidence of recurrence but also reducing the likelihood of infection. Immunomodulators, therefore, might be used either as a primary cancer therapy or as an adjuvant to established therapies. In this paper we review recent investigations which support the potential application of two immunomodulators, Isoprinosine and NPT 15392, in cancer therapy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Ballet, J. J., A. M. Morin and M. Agrapart. 1980. Modulation by Isoprinosine of the activation, differentiation and antigen specific responses of human lymphocytes in vitro. 4th Congress of Immunology, Paris, France.

    Google Scholar 

  2. Betts, R. F., R. G. Douglas, Jr., S. D. George and C. J. Rinehart. 1978. Isoprinosine in experimental influenza Ainfection in volunteers. 78th Annual Meeting of the American Society for Microbiology, Las Vegas, Nevada.

    Google Scholar 

  3. Bradshaw, L. J. and H. L. Sumner. 1977. In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection. Ann. N.Y. Acad. Sci. 284: 190–196.

    Article  PubMed  CAS  Google Scholar 

  4. Corey, L., W. Chiang, W. Reeves, W. Stamm, L. Brewer and K. Holmes. 1979. Effect of Isoprinosine on the cellular immune response in initial genital herpes virus infection. Clin. Res 27: 41A.

    Google Scholar 

  5. Deodhar, S. Unpublished observations.

    Google Scholar 

  6. Fenton, J., 1981. Etude en double-insu de l’influence de l’isoprinosine sur les tests immunitaire de patients recevant une irradiation pelvienne. Bull. Cancer. 68: 200.

    Google Scholar 

  7. Florentin, I., L. Kraus, G. Mathe and J. W. Hadden. 1982. In vivo study in mice of the immunopharmacological properties of NPT 15392. In B. Serrou et al (eds.), Proceedings of the international meeting on human cancer immunology. Elsevier- North Holland (in press).

    Google Scholar 

  8. Florentin, I., E. Taylor, M. Davigny, G. Mathe and J. W. Hadden. 1982. Kinetic studies of the immunopharmacologic effects of NPT 15392 in mice. Int. J. Immunopharm. 4: 225–234.

    Article  CAS  Google Scholar 

  9. Fridman, H., R. Calle and A. Morin. 1980. Double-blind study of Isoprinosine influence on immune parameters in solid tumor-bearing patients treated by radiotherapy. Int. J. Immunopharm. 2:: 194.

    Google Scholar 

  10. Goutner, A. 1980. In vitro modulation of natural killer cell activity by Isoprinosine, NPT 15392 and interferon. -Int. J. Immunopharm. 2: 197.

    Google Scholar 

  11. Hadden, J. W. and A. Giner-Sorolla. 1981. Isoprinosine and NPT 15392: modulators of lymphocyte and macrophage development and function. In E. M. Hersh et al (eds.), Augmenting agents in cancer therapy. Raven Press, New York.

    Google Scholar 

  12. Hadden, J. W. and T. Ginsberg. 1982. Immunopharmacology of methisoprinol. International symposium on recent advances in immunomodulators. Viarregio, Italy.

    Google Scholar 

  13. Hadden, J. W., E. M. Hadden and R. G. Coffey. 1976. Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation. Infect. Immun. 13: 382–387.

    PubMed  CAS  Google Scholar 

  14. Hadden, J. W., E. M. Hadden and R. G. Coffey. 1979. Biological significance of the purine salvage pathway. Transplant. Clin. Immunol. 10: 143–153.

    CAS  Google Scholar 

  15. Hadden, J. W., E. M. Hadden, T. Spira, R. Settineri, L. Simon and A. Giner-Sorolla. 1982. Effects of NPT 15392 in vitro on human leukocyte functions. Int. J. Immunopharm. 4: 235–242.

    Article  CAS  Google Scholar 

  16. Hadden, J. W., C. Lopez, R. O’Reilly and E. Hadden. 1977. Levamisole and inosiplex: antiviral agents with immunopotentiating action. Ann. N. Y. Acad. Sci. 284: 139–152.

    Article  PubMed  CAS  Google Scholar 

  17. Hadden, J. W. and J. Wybran. 1981. Immunopotentiators II Isoprinosine, NPT 15392 and Azimexone: modulators of lymphocyte and macrophage development and function. In J. Hadden et al (eds.), Advances in immunopharmacology. Pergamon Press, New York.

    Google Scholar 

  18. Ikehara, S., J. W. Hadden, R. A. Good, D. G. Lunzer and R. N. Pahawa. 1981. In vitro effects of two immunopotentiators, Isoprinosine and NPT 15392, on murine T-cell differentiation and function. Thymus 3: 87–95.

    PubMed  CAS  Google Scholar 

  19. Jones, E. C., B. Binko, R. Settineri and K. Maxwell. 1982. Influence of NPT 15392 on mouse and human lymphocyte responses (in preparation).

    Google Scholar 

  20. Kott, E., N. Gadoth, S. Levin, T. Hahn, V. Bergman, R. Avidor and C. Braun. 1981. Stimulation of the interferon system by Isoprinosine (inosiplex) in subacute sclerosing panencephalitis (SSPE). 13th Symposium of Israeli Immunological Society.

    Google Scholar 

  21. Merluzzi, V. J., M. M. Walker, N. Williams, B. Susskind, J. W. Hadden and R. B. Faanes. 1982. Immunoenhancing activity of NPT 15392: a potential immune response modifier. Int. J. Immunopharm. 4: 219–224.

    Article  CAS  Google Scholar 

  22. Micksche, M., E. M. Kokoschka, H. Rainer and A. Uchida. 1982. Augmentation of natural killer (NK) cell activity in cancer patients by NPT 15392. Int. J. Immunopharm. 4: 283.

    Article  Google Scholar 

  23. Morin, A., J. L. Touraine, G. Renoux and J. W. Hadden. 1980. Isoprinosine as an immunomodulating agent. Symposium of New Trends in Human Immunology and Cancer Immunotherapy, Montpellier, France.

    Google Scholar 

  24. Moulias, R., J. Proust, M. Marescot, M. Piette and A. Devulecharbrolle. 1978. Action of Isoprinosine (inosiplex) on the immunological parameters of aged people. 7th International Congress of Pharmacology. Paris, France.

    Google Scholar 

  25. Sato, S. and M. Tsurufuji. 1980. NPT 15392: immunorestorative effects in tumor-suppressed mice. Int. J. Immunopharm. 2: 200.

    Article  Google Scholar 

  26. Sato, S. Unpublished observations.

    Google Scholar 

  27. Schaison, G., E. Gluckman, J. F. Souilllet and J. M. Turc. 1980. Isoprinosine curative and prophylactic treatment of viral infections in patients with malignant hematologic disorders. 4th International Congress of Immunology. Paris, France.

    Google Scholar 

  28. Simon, L. N., A. Giner-Sorolla and J. W. Hadden. 1980. NPT 15392 a novel immunomodulating agent. 4th International Congress of Immunology. Paris, France.

    Google Scholar 

  29. Simon, L. N. and A. J. Glasky. 1978. Isoprinosine: an overview. Cancer Treatment Report. 62: 1963–1969.

    CAS  Google Scholar 

  30. Simon, L. N., R. Settineri, E. P Pfadenhauer, C. Jones, K. Maxwell and A. J. Glasky. 1980. NPT 15392: a pharmacologic and toxicologic profile. Int. J. Immunopharm. 2: 200.

    Article  Google Scholar 

  31. Talpaz, M. and G. Mavligit. 1982. Immune restoration augmentation by Isoprinosine in cancer patients. 2nd International Conference of Immunopharmacology. Washington, D. C.

    Google Scholar 

  32. Touraine, J. L., J. W. Hadden and F. Touraine. 1979. Isoprinosine-induced T-cell differentiation and T-cell suppressor activity in humans. 19th International Conference on Antimicrobial Agents and Chemotherapy., Boston, Mass.

    Google Scholar 

  33. Touraine, J., G. Gay-Ferret, K. Sanadji, 0. Othmane, G. Fournie and F. Touraine. 1982. Syngergistic effect with NPT 15392 in vitro and activity on suppressor T-lymphocytes in autoimmune mice in vivo. Internal Symposium on New Trends in Human Immunology and Cancer Immunotherapy. Montpellier, France.

    Google Scholar 

  34. Tsang, K. Y., C. B. Phillips, M. J. Gnagy and H. H. Fudenberg. 1982. In vivo and in vitro effects of NPT 15392 on the immune responses of hamsters. Fed. Proc. 41: 812.

    Google Scholar 

  35. Tsang, K. Y., M. J. Gnagy, C. B. Phillips and H. H. Fudenberg. 1981. In vitro effects of Isoprinosine (Iso) on the immune responses of cancer patients. Proceedings 13th International Cancer Congress. Seattle, Washington.

    Google Scholar 

  36. Wybran, J. 1978. Inosiplex, a stimulating agent for normal human T-cells and human leukocytes. J. Immunology. 121: 1184–1187.

    Google Scholar 

  37. Wybran, J. 1981. Immunomodulatory properties of Isoprinosine in man: in vitro and in vivo data. International Symposium on New Trends in Human Immunology and Cancer Iumtunotherapy. Montpellier, France.

    Google Scholar 

  38. Wybran, J. 1980. NPT 15392, a new synthetic immunomodulatory agent: human, in vitro and in vivo (cancer patients) effects. Int. J. Immunopharm. 2: 193.

    Google Scholar 

  39. Wybran, J. 1982. Immunomodulatory properties of NPT 15392 in man: in vitro and in vivo. Int. J. Immunopharm. 4: 292.

    Google Scholar 

  40. Wybran, J., J. P. Famaey, R. Gortz, I. Dab, A. Malfroot and T. Appelboom. 1982. Inosiplex (Isoprinosine): a review of its immunological and clinical effects in disease. In Advances in pharmacology and therapeutics I I. Pergamon Press, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Newport Pharmaceuticals International, Inc., Newport Beach, California, USA

    L. N. Simon, F. K. Hoehler & D. T. McKenzie

  2. University of South Florida College of Medicine, Tampa, Florida, USA

    J. W. Hadden

Authors
  1. L. N. Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. K. Hoehler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. T. McKenzie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. W. Hadden
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida, Tampa, Florida, USA

    Thomas Klein , Steven Specter , Herman Friedman  & Andor Szentivanyi , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer Science+Business Media New York

About this chapter

Cite this chapter

Simon, L.N., Hoehler, F.K., McKenzie, D.T., Hadden, J.W. (1983). Isoprinosine and NPT 15392: Immunomodulation and Cancer. In: Klein, T., Specter, S., Friedman, H., Szentivanyi, A. (eds) Biological Response Modifiers in Human Oncology and Immunology. Advances in Experimental Medicine and Biology, vol 166. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1410-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1410-4_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1412-8

  • Online ISBN: 978-1-4757-1410-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation